Plasma urea cycle metabolite levels and the risk of moyamoya disease

Plasma urea cycle metabolite levels and the risk of moyamoya disease

Background and purposeUrea cycle metabolites are expected to be the biomarkers for cerebrovascular diseases. However, the effects of circulating urea cycle metabolites on the risk of MMD and its subcategories remain unclear. The aim of this study was to prospectively investigate the association betw...

Full description

Bibliographic Details
Main Authors: Xiaofan Yu, Peicong Ge, Yuanren Zhai, Wei Liu, Qian Zhang, Xun Ye, Xingju Liu, Rong Wang, Yan Zhang, Jizong Zhao, Dong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Neuroscience
Subjects:
moyamoya disease
urea cycle
ornithine
arginine
risk factors
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2023.1163733/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2023.1163733/full

Similar Items